Details van artikel 125 van 426 gevonden artikelen
13 Efficacy on individualized starting dose (ISD) and fixed starting dose (FSD) of niraparib per investigator-assessment (IA) in newly diagnosed advanced ovarian cancer (OC)
Titel:
13 Efficacy on individualized starting dose (ISD) and fixed starting dose (FSD) of niraparib per investigator-assessment (IA) in newly diagnosed advanced ovarian cancer (OC)
Auteur:
Graybill, W. Mirza, M. González-Martin, A. O’Malley, D. Gaba, L. Yap, O.W.S. Guerra, E. Rose, P.G. Baurain, J. Ghamande, S. Denys, H. Prendergast, E. Pisano, C. Follana, P. Braicu, E.I. Calvert, P.M. Korach, J. Li, Y. Gupta, D. Monk, B.J.
Verschenen in:
International journal of gynecological cancer
Paginering:
Jaargang 30 () nr. S3 pagina's A10
Jaar:
2020
Inhoud:
Uitgever:
Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Bronbestand:
Elektronische Wetenschappelijke Tijdschriften
Details van artikel 125 van 426 gevonden artikelen